Company Profile
Haorui Enterprises Ltd. is a prominent chemical company based in China, committed to providing high-quality chemical products to a diverse range of industries. Established in 1986, the company has steadily expanded its product portfolio and strengthened its market presence over the years.
Driven by a focus on research and development, Haorui Enterprises Ltd. continuously innovates to meet the evolving needs of its customers. The company's dedicated team of experts work diligently to develop new and specialized chemical solutions, ensuring consistent quality and safety standards.
Haorui Enterprises' customer-centric approach is a key differentiator, with a talented sales and marketing team providing personalized support and customized solutions to clients. Additionally, the company's commitment to environmental sustainability is reflected in its eco-friendly production processes.
As a respected player in the chemical industry, Haorui Enterprises Ltd. has established a strong foothold in the market, leveraging its technical expertise, quality focus, and exceptional customer service to drive growth and success.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Cimetidine |
Guanidine,N-cyano-N′′-methyl-N′-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]-;Guanidine,N-cyano-N′-methyl-N′′-[2-[[(5-methyl-1H-imidazol-4-yl)methyl]thio]ethyl]-;N-Cyano-N′′-methyl-N′-[2-[[(4-methyl-1H-imidazol-5-yl)methyl]thio]ethyl]guanidine;Cimetidine;N-Cyano-N′-methyl-N′′-[2-((4-methyl-5-imidazolyl)-methylthio)ethyl]guanidine;Tagamet;Eureceptor;Histodil;Biomet;Ulcimet;Cimetag;Dyspamet;Acinil;Tametin;Peptol;Ulcofalk;Cimal;Tratul;Ulcerfen;Ulhys;Ulcomedina;Edalene;Cimetum;SKF 92334;Ulcedin;Ulcedine;Gastromet;Ulcomet;Acibilin;NSC 335308;Ulcerex;Tamagret;Fremet;Tagamet HB 200;Tagamet HB;1-Cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine;79347-40-3 |
51481-61-9 | Inquiry | |
Docetaxel |
Benzenepropanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,(αR,βS)-;Benzenepropanoic acid,β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-,12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester,[2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-;7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.;RP 56976;Docetaxel;Taxotere;N-Debenzoyl-N-tert-butoxycarbonyl-10-deacetyltaxol;Docetaxol;Docetere;Taxotel;SID 530;Duopafei;Docefrez;BIND 014;Miradocetaxel;CKD 810;CRLX 301;ATI 1123;216252-50-5;129522-72-1 |
114977-28-5 | Inquiry | |
Glimepiride |
1H-Pyrrole-1-carboxamide,3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-;1H-Pyrrole-1-carboxamide,3-ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-,trans-;3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide;Glimepiride;HOE 490;Amaryl;trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl] 2-oxo-1H-pyrrole-1-carboxamide;Glimperide;Glirid;Diameprid;Glimax;Limeral;Dibiglim;GlucoNovax;ZINC 537791 |
93479-97-1 | Inquiry | |
Irinotecan hydrochloride trihydrate |
[1,4′-Bipiperidine]-1′-carboxylic acid,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester,hydrochloride,hydrate (1:1:3);[1,4′-Bipiperidine]-1′-carboxylic acid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester,monohydrochloride,trihydrate,(S)-;[1,4′-Bipiperidine]-1′-carboxylic acid,(4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl ester,monohydrochloride,trihydrate;1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline,[1,4′-bipiperidine]-1′-carboxylic acid deriv.;Irinotecan hydrochloride hydrate;Irinotecan hydrochloride trihydrate;Onivyde;Onivyde pegylated liposomal |
136572-09-3 | Inquiry |